HRP20161342T1 - Antimikrobni zavoj - Google Patents
Antimikrobni zavoj Download PDFInfo
- Publication number
- HRP20161342T1 HRP20161342T1 HRP20161342TT HRP20161342T HRP20161342T1 HR P20161342 T1 HRP20161342 T1 HR P20161342T1 HR P20161342T T HRP20161342T T HR P20161342TT HR P20161342 T HRP20161342 T HR P20161342T HR P20161342 T1 HRP20161342 T1 HR P20161342T1
- Authority
- HR
- Croatia
- Prior art keywords
- bandage
- pharmaceutically acceptable
- acceptable salt
- chlorhexidine
- silver
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims 3
- 150000003839 salts Chemical class 0.000 claims 13
- 229910052709 silver Inorganic materials 0.000 claims 13
- 239000004332 silver Substances 0.000 claims 13
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 7
- 229960003260 chlorhexidine Drugs 0.000 claims 7
- 239000007787 solid Substances 0.000 claims 6
- 239000010410 layer Substances 0.000 claims 4
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000002745 absorbent Effects 0.000 claims 2
- 239000002250 absorbent Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 210000000416 exudates and transudate Anatomy 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 239000002344 surface layer Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0076—Sprayable compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/206—Biguanides, e.g. chlorohexidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0213—Holding devices, e.g. on the body where the catheter is attached by means specifically adapted to a part of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/0266—Holding devices, e.g. on the body using pads, patches, tapes or the like
- A61M2025/0273—Holding devices, e.g. on the body using pads, patches, tapes or the like having slits to place the pad around a catheter puncturing site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Claims (10)
1. Antimikrobni zavoj koji sadrži relativni dio (30) zavoja s antimikrobnim svojstvima koji ima relativnu površinu zavoja (110), te dio (30) zavoja sadrži: klorheksidin i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina zavoja, u opsegu između 0.40 i 1.125 g/m2, i srebro i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina zavoja većoj od ili jednakoj 0.1 mg/m2.
2. Zavoj prema prethodnom zahtjevu, naznačen time da je količina klorheksidina i/ili njegove farmaceutski prihvatljive soli u krutom stanju, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina zavoja, veća od ili jednaka 0.425 mg/m2.
3. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da je količina srebra i/ili njegove farmaceutski prihvatljive soli u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina zavoja, veća od ili jednaka 0.2 mg/m2.
4. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da dio (30) zavoja ima omjer između njegove težine i površine zavoja koji je u opsegu između 100 i 150 g/m2, te sadrži: klorheksidin i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina klorheksidin diglukonata/površina lijeka, u rasponu između 0.500 i 0.875 g/m2 i odgovara relativnom postotku, izračunato kao ekvivalentna težina klorheksidin diglukonata/ težina dijela zavoja (30) u postotcima, u rasponu između 0.40 i 0.70%; i srebro i/ili njegovu farmaceutski prihvatljivu sol u krutom stanju u relativnoj količini, izračunato kao ekvivalentna težina metalnog srebra/površina lijeka, u rasponu između 50 i 300 mg/m2 i odgovara relativnom postotku, izračunato kao ekvivalentna težina metalnog srebra/težina dijela zavoja u postotcima, koji se nalazi između 0.04% i 0.24%.
5. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da su kloroheksidin i/ili njegova farmaceutski prihvatljiva sol i/ili srebro i/ili njegova farmaceutski prihvatljiva sol u obliku nanočestica (2, 12).
6. Zavoj prema prethodnom zahtjevu, naznačen time da svaka pojedinačna nanočestica (2, 12) sadrži oba sastojka kloroheksidin i/ili njegovu farmaceutski prihvatljivu sol i srebro i/ili njegovu farmaceutski prihvatljivu sol.
7. Zavoj prema bilo kojem od prethodnih zahtjeva, naznačen time da dio (30) zavoja sadrži element metalnog srebra koji se bira iz skupine koju čine: mreža ili mrežica koja je izvedena korištenjem žica metalnog srebra i tankog perforiranog sloja metalnog srebra; te pri čemu su klorheksidin i/ili njegova farmaceutski prihvatljiva sol smješteni na metalni element.
8. Zavoj prema bilo kojem od prethodnih zahtjeva od 1 do 6, naznačen time da relativni dio (30) zavoja dodatno sadrži: površinski sloj (110) koji označava površinu zavoja za kontakt s kožom pacijenta, sloj je propustan za krv i tjelesni eksudat; i barem upijajući unutrašnji sloj (120) za upijanje krvi i tjelesnog eksudata; pri čemu barem jedan od površinskog sloja (110) i/ili unutrašnjeg upijajućeg sloja (120) sadrži klorheksidin i/ili njegovu farmaceutski prihvatljivu sol i srebro i/ili njegovu farmaceutski prihvatljivu sol.
9. Zavoj prema bilo kojem od prethodnih zahtjeva za zaštitu izlazne točke kod usađivanja katetera kod pacijenta, u kojem je relativni dio (30) zavoja prilagođen na takav način da okružuje kateter na dijelu gdje kateter izlazi iz tijela pacijenta kada se površina s lijekom (110) primjenjuje na kožu na mjestu izlaza kod presađivanja.
10. Zavoj prema prethodnom zahtjevu, naznačen time da relativni dio (30) zavoja je izveden sa prorezom (14) koji ima oblik i dimenzije koje su takve da se omogućava prolaz katetera koji je izvan tijela da prijeđe dio (30) zavoja i okružuje dio katetera kada se površina s lijekom (110) primjenjuje na kožu na mjestu izlaza kod presađivanja.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000185A ITBO20120185A1 (it) | 2012-04-06 | 2012-04-06 | Medicazione antimicrobica, composizione antimicrobica e relativo uso |
EP13724402.6A EP2833929B1 (en) | 2012-04-06 | 2013-04-04 | Antimicrobial dressing |
PCT/IB2013/052712 WO2013150487A1 (en) | 2012-04-06 | 2013-04-04 | An anti-microbial dressing, an anti-microbial composition and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20161342T1 true HRP20161342T1 (hr) | 2017-01-27 |
Family
ID=46208637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20161342TT HRP20161342T1 (hr) | 2012-04-06 | 2016-10-13 | Antimikrobni zavoj |
Country Status (14)
Country | Link |
---|---|
US (1) | US20150057617A1 (hr) |
EP (1) | EP2833929B1 (hr) |
JP (1) | JP6213851B2 (hr) |
CN (1) | CN104394896B (hr) |
CA (1) | CA2869367C (hr) |
DK (1) | DK2833929T3 (hr) |
ES (1) | ES2600735T3 (hr) |
HR (1) | HRP20161342T1 (hr) |
IT (1) | ITBO20120185A1 (hr) |
PL (1) | PL2833929T3 (hr) |
PT (1) | PT2833929T (hr) |
RU (1) | RU2014141515A (hr) |
SI (1) | SI2833929T1 (hr) |
WO (1) | WO2013150487A1 (hr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220232950A1 (en) * | 2015-10-16 | 2022-07-28 | Amolifescience Co., Ltd. | Dry cosmetic sheet |
GB201711181D0 (en) | 2017-07-12 | 2017-08-23 | Smith & Nephew | Polymer foam material, device and use |
GB201711183D0 (en) | 2017-07-12 | 2017-08-23 | Smith & Nephew | Antimicrobial or wound care materials, devices and uses |
GB201711179D0 (en) * | 2017-07-12 | 2017-08-23 | Smith & Nephew | Wound care materials, devices and uses |
US20220175585A1 (en) * | 2019-04-01 | 2022-06-09 | 3M Innovative Properties Company | Conformable dressing |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3774567D1 (de) * | 1986-09-20 | 1991-12-19 | Smith & Nephew | Heftpflaster. |
US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
JPH0910296A (ja) * | 1995-06-30 | 1997-01-14 | Unitika Ltd | 体液吸収用品 |
WO2008157092A1 (en) * | 2007-06-20 | 2008-12-24 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
KR20100103834A (ko) * | 2007-12-20 | 2010-09-28 | 아스트라제네카 아베 | 분말 854를 탈응집하는 장치 및 방법 |
CN101224310B (zh) * | 2008-01-18 | 2010-11-03 | 中国人民解放军第四军医大学 | 一种载有抗菌药物纳米微粒的医用创伤敷料 |
US20110038910A1 (en) * | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US10500173B2 (en) * | 2010-06-17 | 2019-12-10 | Covalon Technologies Inc. | Antimicrobial silicone-based wound dressings |
US20130267490A1 (en) * | 2010-08-02 | 2013-10-10 | Ranbaxy Laboratories Limited | Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate |
CZ22394U1 (cs) * | 2011-03-11 | 2011-06-20 | Contipro C, A.S. | Antimikrobiální smes a kryt pro podporu hojení ran s antimikrobiálním úcinkem |
-
2012
- 2012-04-06 IT IT000185A patent/ITBO20120185A1/it unknown
-
2013
- 2013-04-04 ES ES13724402.6T patent/ES2600735T3/es active Active
- 2013-04-04 DK DK13724402.6T patent/DK2833929T3/en active
- 2013-04-04 CN CN201380021395.7A patent/CN104394896B/zh active Active
- 2013-04-04 US US14/389,981 patent/US20150057617A1/en not_active Abandoned
- 2013-04-04 RU RU2014141515A patent/RU2014141515A/ru not_active Application Discontinuation
- 2013-04-04 WO PCT/IB2013/052712 patent/WO2013150487A1/en active Application Filing
- 2013-04-04 CA CA2869367A patent/CA2869367C/en active Active
- 2013-04-04 PL PL13724402T patent/PL2833929T3/pl unknown
- 2013-04-04 SI SI201330335A patent/SI2833929T1/sl unknown
- 2013-04-04 JP JP2015503981A patent/JP6213851B2/ja active Active
- 2013-04-04 PT PT137244026T patent/PT2833929T/pt unknown
- 2013-04-04 EP EP13724402.6A patent/EP2833929B1/en active Active
-
2016
- 2016-10-13 HR HRP20161342TT patent/HRP20161342T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US20150057617A1 (en) | 2015-02-26 |
EP2833929B1 (en) | 2016-07-27 |
JP2015523101A (ja) | 2015-08-13 |
ES2600735T3 (es) | 2017-02-10 |
RU2014141515A (ru) | 2016-05-27 |
CN104394896B (zh) | 2016-12-21 |
WO2013150487A1 (en) | 2013-10-10 |
DK2833929T3 (en) | 2016-10-10 |
ITBO20120185A1 (it) | 2013-10-07 |
CN104394896A (zh) | 2015-03-04 |
SI2833929T1 (sl) | 2017-01-31 |
CA2869367C (en) | 2021-04-27 |
JP6213851B2 (ja) | 2017-10-18 |
CA2869367A1 (en) | 2013-10-10 |
PT2833929T (pt) | 2016-11-04 |
PL2833929T3 (pl) | 2017-08-31 |
EP2833929A1 (en) | 2015-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20161342T1 (hr) | Antimikrobni zavoj | |
Krysiak et al. | Electrospun fibers as carriers for topical drug delivery and release in skin bandages and patches for atopic dermatitis treatment | |
ES2369564T3 (es) | Apósito. | |
ES2657216T3 (es) | Apósito para la piel o para heridas para la cicatrización húmeda | |
Mirhaj et al. | An overview on the recent advances in the treatment of infected wounds: Antibacterial wound dressings | |
EP2644114A3 (en) | Layered tissue thickness compensator | |
FI3551238T3 (fi) | Hajunpoistokoostumuksia, erityisesti yhdessä avannelaitteiden kanssa | |
US20100260824A1 (en) | Antimicrobial Foam Compositions, Articles and Methods | |
DE602007013369D1 (de) | Medizinische vorrichtungen mit einem porösen metalloxid- oder metallmaterial und einer polymerbeschichtung zur freisetzung von therapeutika | |
BRPI0621164B8 (pt) | pó hesmostático, bandagem hesmostática para feridas e método de manufatura de um pó hesmostático | |
ATE498027T1 (de) | Wirkstoffabgebende verbundkörper | |
ES2322218B1 (es) | Compuestos antimicrobianos y apositos que los contienen. | |
Elsner et al. | Highly porous drug-eluting structures: From wound dressings to stents and scaffolds for tissue regeneration | |
WO2012017349A3 (en) | Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate | |
NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
AT413471B (de) | Prophylaxeartikel | |
HRP20130123T1 (hr) | Postupak lijeäśenja bolesti | |
RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
JP2024520383A (ja) | 膣内リング器具 | |
MX360002B (es) | Formulaciones mejoradas para dispositivos médicos recubiertos con medicamento. | |
WO2016116403A8 (en) | Polyurethaneurea solutions for compositions with active ingredients or fragrances | |
HRP20200971T1 (hr) | Modulacija djelovanja epidermalnog faktora rasta koji veže heparin u svrhu zacijeljivanja membrane bubnjića | |
WO2009080321A3 (en) | Lamellar shaped layers in medical devices | |
DE102007050668A1 (de) | Stent mit einem Grundkörper aus einem bioinerten metallischen Implantatwerkstoff | |
HRP20201630T1 (hr) | Sastavi i postupci za liječenje kožnog t-staničnog limfoma |